3
Announcements
Trials
Browse
Landscape
Phase
Phase 3
1
Status
Recruiting
1
Sponsor Class
INDUSTRY
1
Study Type
Interventional
1
Sponsor
Cancer Type
Plasma cell
1
Other hematologic neoplasm
1
Lymphoid
1
Conditions
Multiple Myeloma
1
Lymphoma, Non-Hodgkin
1
Leukemia, Lymphocytic, Chronic, B-Cell
1
Interventions
Cyclophosphamide
88
Rituximab
76
Specimen Handling
75
Magnetic Resonance Spectroscopy
64
Biopsy
60
Vincristine
49
Doxorubicin
48
Prednisone
45
venetoclax
38
obinutuzumab
34
fludarabine
32
Lenalidomide
29
ibrutinib
28
Cytarabine
27
Dexamethasone
26
Methotrexate
25
prednylidene
23
Etoposide
23
zanubrutinib
22
deltacortene
22
CT-P10
22
blinatumomab
21
acalabrutinib
21
Nivolumab
21
fludarabine phosphate
19
merphos
18
Bendamustine Hydrochloride
17
Calcium Dobesilate
16
pembrolizumab
15
X-Rays
15
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Hizentra
×
Lymphoid
×
30 days
×
Clear all
NCT07582432
2026-05-12
SIGMA
Grifols Biologicals, LLC
Phase 3
Recruiting
49 enrolled